Xenon Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell XENE and other ETFs, options, and stocks.About XENE
Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions.
CEOIan C. Mortimer
CEOIan C. Mortimer
Employees327
Employees327
HeadquartersBurnaby, British Columbia
HeadquartersBurnaby, British Columbia
Founded1996
Founded1996
Employees327
Employees327
XENE Key Statistics
Market cap3.42B
Market cap3.42B
Price-Earnings ratio-11.34
Price-Earnings ratio-11.34
Dividend yield—
Dividend yield—
Average volume782.28K
Average volume782.28K
High today$44.57
High today$44.57
Low today$43.28
Low today$43.28
Open price$43.80
Open price$43.80
Volume790.65K
Volume790.65K
52 Week high$46.60
52 Week high$46.60
52 Week low$26.74
52 Week low$26.74
Stock Snapshot
Xenon Pharmaceuticals(XENE) stock is priced at $44.06, giving the company a market capitalization of 3.42B. It carries a P/E multiple of -11.34.
On 2025-12-14, Xenon Pharmaceuticals(XENE) stock moved within a range of $43.28 to $44.57. With shares now at $44.06, the stock is trading +1.8% above its intraday low and -1.1% below the session's peak.
Trading activity shows a volume of 790.65K, compared to an average daily volume of 782.28K.
Over the past 52 weeks, Xenon Pharmaceuticals(XENE) stock has traded between a high of $46.60 and a low of $26.74.
Over the past 52 weeks, Xenon Pharmaceuticals(XENE) stock has traded between a high of $46.60 and a low of $26.74.
Analyst ratings
100%
of 20 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own XENE. This list is generated using Robinhood data, and it’s not a recommendation.